Lung Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are 18 years old or older
- You have been diagnosed with a specific type of lung cancer (advanced non-squamous non-small cell lung cancer) confirmed by a tissue sample test
- Your cancer has a specific genetic change called a HER2 insertion or amplification (confirm with trial site)
- You have not received any previous treatment for this cancer (this would be your first time being treated for it)
- Your planned treatment involves chemotherapy, or chemotherapy combined with a type of immunotherapy drug called a PD-1 antibody
Who may not be able to join:
- You have already received any cancer treatment before joining the trial
- You have a medical reason why chemotherapy would not be safe for you (confirm with trial site)
- You are currently pregnant or breastfeeding
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Yongchang Zhang, MD, Hunan Cancer Hospital
Phone: +8613873123436
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
PFS
Can't join this trial?
Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.